| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BIT.22366 |
| P8608 | Fatcat ID | release_mlnkzbtnvbecbdoebt42ucceyy |
| P698 | PubMed publication ID | 19418562 |
| P5875 | ResearchGate publication ID | 24404647 |
| P2093 | author name string | Mandy B Esch | |
| Michael L Shuler | |||
| Raymond P Glahn | |||
| Gretchen J Mahler | |||
| P2860 | cites work | Physiological parameter values for physiologically based pharmacokinetic models | Q41556435 |
| P433 | issue | 1 | |
| P304 | page(s) | 193-205 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Biotechnology and Bioengineering | Q4915339 |
| P1476 | title | Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity | |
| P478 | volume | 104 |
| Q38567885 | 3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip |
| Q38684521 | A Review of the Application of Body-on-a-Chip for Drug Test and Its Latest Trend of Incorporating Barrier Tissue |
| Q39027034 | A bioartificial renal tubule device embedding human renal stem/progenitor cells |
| Q44870856 | A microengineered collagen scaffold for generating a polarized crypt-villus architecture of human small intestinal epithelium |
| Q89035663 | A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells |
| Q30422679 | Accelerating drug discovery via organs-on-chips. |
| Q30440267 | Advances in microfluidic materials, functions, integration, and applications |
| Q38029121 | Advances in microfluidics for drug discovery |
| Q92556132 | Application of chemical reaction engineering principles to 'body-on-a-chip' systems |
| Q90298646 | Barriers-on-chips: Measurement of barrier function of tissues in organs-on-chips |
| Q30358385 | Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing |
| Q98466534 | Biomedical Application of Functional Materials in Organ-on-a-Chip |
| Q26768245 | Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniques |
| Q35739950 | Biomimetic tissues on a chip for drug discovery. |
| Q34088840 | Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury |
| Q39458410 | Cassia angustifolia extract is not hepatotoxic in an in vitro and in vivo study |
| Q43160625 | Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design |
| Q51374752 | Design and demonstration of a pumpless 14 compartment microphysiological system. |
| Q34097011 | Development of disposable PDMS micro cell culture analog devices with photopolymerizable hydrogel encapsulating living cells |
| Q38163391 | Droplet-based microfluidics: enabling impact on drug discovery |
| Q38799238 | Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions |
| Q64101563 | Emerging Role of Organ-on-a-Chip Technologies in Quantitative Clinical Pharmacology Evaluation |
| Q30477371 | Engineering hydrogels as extracellular matrix mimics |
| Q51072946 | First pass intestinal and liver metabolism of paracetamol in a microfluidic platform coupled with a mathematical modeling as a means of evaluating ADME processes in humans. |
| Q38774307 | From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues |
| Q40189708 | Gastrointestinal microphysiological systems |
| Q39253982 | High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model |
| Q33893475 | How multi-organ microdevices can help foster drug development |
| Q51541144 | Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. |
| Q35532165 | Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling |
| Q60953886 | In Vitro Immune Organs-on-Chip for Drug Development: A Review |
| Q38287065 | In vitro micro-physiological models for translational immunology |
| Q48176405 | Incorporation of resident macrophages in engineered tissues: Multiple cell type response to microenvironment controlled macrophage-laden gelatine hydrogels. |
| Q51507444 | Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®. |
| Q41669826 | Influence of shear stress and size on viability of endothelial cells exposed to gold nanoparticles |
| Q37764345 | Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling |
| Q91650386 | Intestine-Liver Axis On-Chip Reveals the Intestinal Protective Role on Hepatic Damage by Emulating Ethanol First-Pass Metabolism |
| Q38877430 | Investigation of acetaminophen toxicity in HepG2/C3a microscale cultures using a system biology model of glutathione depletion |
| Q39570346 | Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip. |
| Q41441454 | Investigation of omeprazole and phenacetin first-pass metabolism in humans using a microscale bioreactor and pharmacokinetic models |
| Q39344014 | Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells. |
| Q35826421 | Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. |
| Q27011459 | Microfabricated mammalian organ systems and their integration into models of whole animals and humans |
| Q45924666 | Microfabrication of human organs-on-chips. |
| Q36501907 | Microfabrication technologies for oral drug delivery |
| Q26774240 | Microfluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering. |
| Q37844444 | Microfluidic devices for in vitro studies on liver drug metabolism and toxicity |
| Q51510970 | Microfluidic organs-on-chips. |
| Q41704486 | Microfluidics for Antibiotic Susceptibility and Toxicity Testing |
| Q37082323 | Microfluidics meets metabolomics to reveal the impact of Campylobacter jejuni infection on biochemical pathways |
| Q51459366 | Microfluidics-based 3D cell culture models: Utility in novel drug discovery and delivery research. |
| Q33645219 | Microphysiological systems and low-cost microfluidic platform with analytics |
| Q37973002 | Microtechnology for mimicking in vivo tissue environment |
| Q41704262 | Microtechnology-Based Multi-Organ Models |
| Q26748486 | Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges |
| Q59133328 | Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age |
| Q34143148 | Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems. |
| Q38004843 | Modeling life |
| Q41869926 | Modular microfluidic system as a model of cystic fibrosis airways. |
| Q39664131 | Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue |
| Q35577829 | Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. |
| Q47283219 | Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges |
| Q38816248 | Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery. |
| Q39238084 | NutriChip: nutrition analysis meets microfluidics |
| Q51538333 | On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic 'body-on-a-chip' devices. |
| Q92888062 | Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review |
| Q38905001 | Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems |
| Q47637355 | Organ-on-a-Chip Technology for Reproducing Multiorgan Physiology |
| Q39375469 | Organ-on-a-chip devices advance to market |
| Q38137976 | Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening |
| Q57238729 | Organs on microfluidic chips: A mini review |
| Q38195304 | Organs-on-a-chip: a new tool for drug discovery |
| Q36001471 | Progress and future of in vitro models to study translocation of nanoparticles. |
| Q28390771 | Protein expression profiles of intestinal epithelial co-cultures: effect of functionalised carbon nanotube exposure |
| Q37213510 | Proteomic profiling of halloysite clay nanotube exposure in intestinal cell co-culture |
| Q55931893 | RETRACTED: ZnO nanoparticles affect intestinal function in an in vitro model |
| Q47414425 | Self-contained, low-cost Body-on-a-Chip systems for drug development |
| Q88396849 | Silicon dioxide nanoparticle exposure affects small intestine function in an in vitro model |
| Q90229721 | Stem cell-based Lung-on-Chips: The best of both worlds? |
| Q28086851 | TEER measurement techniques for in vitro barrier model systems |
| Q37967417 | The current status of alternatives to animal testing and predictive toxicology methods using liver microfluidic biochips |
| Q37174716 | The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? |
| Q97093738 | The past, present and future of intestinal in vitro cell systems for drug absorption studies |
| Q51549876 | Tissue models: a living system on a chip. |
| Q34143269 | Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure |
| Q90023898 | ZnO nanoparticles affect nutrient transport in an in vitro model of the small intestine |
Search more.